| Dr Kristin Lynch Grimes, DO | |
|
6516 E Myrtle Ave, Baker, LA 70714-4348 | |
| (225) 774-7320 | |
| (225) 774-5432 |
| Full Name | Dr Kristin Lynch Grimes |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 11 Years |
| Location | 6516 E Myrtle Ave, Baker, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558603563 | NPI | - | NPPES |
| 2329146 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 301033 (Louisiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dr Ks Family Medicine | 9335426121 | 2 |
News Archive
A European consortium of epilepsy researchers has reported the discovery of a new gene involved in severe childhood epilepsy. Using a novel combination of technologies, including trio exome sequencing of patient/parental DNA and genetic studies in the tiny larvae of zebrafish, the EuroEPINOMICS RES consortium found that mutations in the gene CHD2 are responsible for a subset of epilepsy patients with symptoms similar to Dravet syndrome - a severe form of childhood epilepsy that is in many patients resistant to currently available anti-epileptic drugs.
Among patients with idiopathic (of unknown cause) gastroparesis, use of the antidepressant nortriptyline compared with placebo for 15 weeks did not result in improvement in overall symptoms, according to a study appearing in the December 25 issue of JAMA.
Verenium Corporation, a pioneer in the development and commercialization of high-performance enzymes solutions, today announced an agreement with Desmet Ballestra Group s.a., a leading global solutions provider in the field of engineering and delivery of installations and equipment for the edible oil and fats and biodiesel industries, to jointly market the Purifine enzymatic degumming process, which combines Verenium's Purifine PLC enzyme and Desmet Ballestra's engineering services and equipment.
Each year more than 360 billion cigarettes are smoked in the United States. Where do all those butts go? Public roads, waterways, parks and beaches. New research released today further demonstrates the negative impact that cigarette filters and discarded cigarette butts have on the environment.
The American Heart Association (AHA) applauds the efforts of New York City to work with the packaged and restaurant foods industry to reduce the amount of salt in the food supply. These efforts serve an important role in bringing both the public health community and food industry together to create solutions and help Americans live healthier lives.
› Verified 7 days ago
| Entity Name | Dr Ks Family Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265971147 PECOS PAC ID: 9335426121 Enrollment ID: O20170504000198 |
News Archive
A European consortium of epilepsy researchers has reported the discovery of a new gene involved in severe childhood epilepsy. Using a novel combination of technologies, including trio exome sequencing of patient/parental DNA and genetic studies in the tiny larvae of zebrafish, the EuroEPINOMICS RES consortium found that mutations in the gene CHD2 are responsible for a subset of epilepsy patients with symptoms similar to Dravet syndrome - a severe form of childhood epilepsy that is in many patients resistant to currently available anti-epileptic drugs.
Among patients with idiopathic (of unknown cause) gastroparesis, use of the antidepressant nortriptyline compared with placebo for 15 weeks did not result in improvement in overall symptoms, according to a study appearing in the December 25 issue of JAMA.
Verenium Corporation, a pioneer in the development and commercialization of high-performance enzymes solutions, today announced an agreement with Desmet Ballestra Group s.a., a leading global solutions provider in the field of engineering and delivery of installations and equipment for the edible oil and fats and biodiesel industries, to jointly market the Purifine enzymatic degumming process, which combines Verenium's Purifine PLC enzyme and Desmet Ballestra's engineering services and equipment.
Each year more than 360 billion cigarettes are smoked in the United States. Where do all those butts go? Public roads, waterways, parks and beaches. New research released today further demonstrates the negative impact that cigarette filters and discarded cigarette butts have on the environment.
The American Heart Association (AHA) applauds the efforts of New York City to work with the packaged and restaurant foods industry to reduce the amount of salt in the food supply. These efforts serve an important role in bringing both the public health community and food industry together to create solutions and help Americans live healthier lives.
› Verified 7 days ago
| Entity Name | The Louisiana Center For Health And Wellness Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821795337 PECOS PAC ID: 6608232897 Enrollment ID: O20230512001695 |
News Archive
A European consortium of epilepsy researchers has reported the discovery of a new gene involved in severe childhood epilepsy. Using a novel combination of technologies, including trio exome sequencing of patient/parental DNA and genetic studies in the tiny larvae of zebrafish, the EuroEPINOMICS RES consortium found that mutations in the gene CHD2 are responsible for a subset of epilepsy patients with symptoms similar to Dravet syndrome - a severe form of childhood epilepsy that is in many patients resistant to currently available anti-epileptic drugs.
Among patients with idiopathic (of unknown cause) gastroparesis, use of the antidepressant nortriptyline compared with placebo for 15 weeks did not result in improvement in overall symptoms, according to a study appearing in the December 25 issue of JAMA.
Verenium Corporation, a pioneer in the development and commercialization of high-performance enzymes solutions, today announced an agreement with Desmet Ballestra Group s.a., a leading global solutions provider in the field of engineering and delivery of installations and equipment for the edible oil and fats and biodiesel industries, to jointly market the Purifine enzymatic degumming process, which combines Verenium's Purifine PLC enzyme and Desmet Ballestra's engineering services and equipment.
Each year more than 360 billion cigarettes are smoked in the United States. Where do all those butts go? Public roads, waterways, parks and beaches. New research released today further demonstrates the negative impact that cigarette filters and discarded cigarette butts have on the environment.
The American Heart Association (AHA) applauds the efforts of New York City to work with the packaged and restaurant foods industry to reduce the amount of salt in the food supply. These efforts serve an important role in bringing both the public health community and food industry together to create solutions and help Americans live healthier lives.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kristin Lynch Grimes, DO 6516 E Myrtle Ave, Baker, LA 70714-4348 Ph: (225) 774-7320 | Dr Kristin Lynch Grimes, DO 6516 E Myrtle Ave, Baker, LA 70714-4348 Ph: (225) 774-7320 |
News Archive
A European consortium of epilepsy researchers has reported the discovery of a new gene involved in severe childhood epilepsy. Using a novel combination of technologies, including trio exome sequencing of patient/parental DNA and genetic studies in the tiny larvae of zebrafish, the EuroEPINOMICS RES consortium found that mutations in the gene CHD2 are responsible for a subset of epilepsy patients with symptoms similar to Dravet syndrome - a severe form of childhood epilepsy that is in many patients resistant to currently available anti-epileptic drugs.
Among patients with idiopathic (of unknown cause) gastroparesis, use of the antidepressant nortriptyline compared with placebo for 15 weeks did not result in improvement in overall symptoms, according to a study appearing in the December 25 issue of JAMA.
Verenium Corporation, a pioneer in the development and commercialization of high-performance enzymes solutions, today announced an agreement with Desmet Ballestra Group s.a., a leading global solutions provider in the field of engineering and delivery of installations and equipment for the edible oil and fats and biodiesel industries, to jointly market the Purifine enzymatic degumming process, which combines Verenium's Purifine PLC enzyme and Desmet Ballestra's engineering services and equipment.
Each year more than 360 billion cigarettes are smoked in the United States. Where do all those butts go? Public roads, waterways, parks and beaches. New research released today further demonstrates the negative impact that cigarette filters and discarded cigarette butts have on the environment.
The American Heart Association (AHA) applauds the efforts of New York City to work with the packaged and restaurant foods industry to reduce the amount of salt in the food supply. These efforts serve an important role in bringing both the public health community and food industry together to create solutions and help Americans live healthier lives.
› Verified 7 days ago
Dr. Mark Christian Mouton, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12880 Plank Rd, Baker, LA 70714 Phone: 225-774-7111 Fax: 225-774-7111 | |
Ernest Gene Thompson Jr., MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12902 Plank Road, 5825 Airline Highway, Baker, LA 70714 Phone: 225-774-3883 Fax: 225-774-7777 | |
Kent M Rhodes, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6516 E Myrtle Ave, Baker, LA 70714 Phone: 225-765-5500 Fax: 225-774-5432 |